Because public health and innovation are no longer national issues, regulatory authorities must apply a global view to oversight.
No takes yet. Share an insight, caveat, or question.
Zerhouni et al. (2016) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: